Media formats available:
Recommended
- When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment optionsExpanding evidence on SGLT2i: Where are we now and what can we expect?
Prof. Scott Solomon
- When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment optionsBenefits and evolving insights on SGLT2i in the spectrum of LVEF
Prof. Carolyn Lam, MD
- When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment optionsThe clinical challenges of initiating guideline recommended therapy in HF
Prof. John McMurray, MD